---
symbol: "HIMS"
name: "Hims & Hers"
date: 2026-08-20
change_pct: 11.56549754704547
direction: "up"
event_type: "theme_sympathy"
url: "https://perplo.app/why/HIMS/2026-08-20"
updated_at: 2026-08-20T11:06:41.950Z
---

# Why Hims & Hers (HIMS) rose 11.57% on August 20, 2026

Hims & Hers (HIMS) rose 11.57% on August 20, 2026 — Moderna cancer vaccine breakthrough lifts biopharma.

## What happened

Moderna disclosed a cancer-vaccine breakthrough, triggering a broad biopharma rally that lifted the Healthcare & Biotech theme.

## Why it moved

Hims rose in sympathy with sector peers as Moderna's vaccine success reignited conviction in the biotech pipeline; the broader basket moved higher on restored optimism around novel therapeutics, lifting Hims alongside…

## Why it matters

The Healthcare & Biotech theme has stalled waiting for fresh clinical validation after a three-month obesity-drug and vaccine surge; Moderna's cancer-vaccine win signals that pipeline momentum is alive, re-engaging…

## What would break the thesis

If Moderna's vaccine data falters in later trials or obesity-drug adoption slows below expectations, the sector-wide momentum reverses and Hims loses its tailwind.

## Sources

- [Moderna’s cancer-vaccine breakthrough drives broad biopharma stock rally](https://www.marketwatch.com/story/modernas-cancer-vaccine-breakthrough-drives-broad-biopharma-stock-rally-ff2816aa?mod=mw_rss_topstories) — MarketWatch

---

Trade HIMS perpetual futures 24/7 onchain: https://perplo.app/asset/HIMS